Endoscopic ultrasound (EUS) has long been a valuable diagnostic and therapeutic tool in gastroenterology, traditionally confined to hospital settings due to high costs and technical requirements. This white paper introduces the EndoSound Vision System™ (EVS™), a groundbreaking solution that makes EUS accessible and profitable for Ambulatory Surgical Centers (ASCs) and smaller hospitals. By addressing traditional barriers to EUS adoption in outpatient settings, EVS is poised to transform the landscape of advanced endoscopy, improving patient care, physician satisfaction, and ASC profitability.
Background: EUS in Gastroenterology
Endoscopic ultrasound (EUS) has been a cornerstone of advanced gastroenterology for over three decades. This hybrid technique combines endoscopy with high-frequency ultrasound, allowing for detailed imaging of the gastrointestinal tract and adjacent structures. EUS has proven invaluable for:
Diagnosis and staging of gastrointestinal cancers
Evaluation of submucosal lesions
Assessment of pancreaticobiliary disorders
Guided fine-needle aspiration (FNA) and biopsy procedures
Therapeutic interventions such as pseudocyst drainage and celiac plexus neurolysis
Despite its clinical utility, EUS has primarily been confined to hospital-based settings due to several limiting factors.
Traditional Barriers to EUS in ASCs
Historically, several factors have prevented the widespread adoption of EUS in the ASC:
High Capital Costs: Traditional EUS systems require substantial upfront investment, often exceeding $200,000 for the ultrasound hardware alone.
Additional Scope Requirements: Conventional EUS systems necessitate the purchase of specialized echoendoscopes, which can cost over $80,000 each. This represents a significant additional expense beyond the ultrasound hardware.
Extensive Training: The complexity of traditional EUS systems demands extensive training for endoscopy technicians, increasing operational costs and potential scheduling difficulties
Space Constraints: Many ASCs lack the physical space to accommodate bulky EUS equipment, limiting their ability to offer this service.
These barriers have effectively relegated EUS to larger hospital settings, limiting access for patients and potentially increasing healthcare costs.
The EVS Solution
The EVS represents a paradigm shift in EUS technology, specifically designed to overcome the traditional barriers to ASC adoption. Key advantages include:
Low Capital Cost: The EVS is offered at a fraction of the cost of traditional EUS systems, making it accessible to a wider range of healthcare providers. Furthermore, making the case for Echo-Endoscopy, the concept of combining upper endoscopy with EUS to maximize the diagnostic yield, is possible.
Compatibility with Existing Endoscopes: Unlike traditional systems, EVS works with standard endoscopes already in use at ASCs. This eliminates the need for additional expensive echoendoscopes, allowing for immediate implementation regardless of the current scope vendor.
High-Quality Imaging: Despite its cost-effectiveness, EVS provides high-resolution ultrasound images comparable to those produced by many traditional systems.
Minimal Additional Training: The system’s user-friendly interface and compatibility with existing endoscopes minimize the learning curve for endoscopy technicians.
Compact Design: The EVS’s small footprint allows for easy integration into existing ASC environments without requiring additional space. Additionally, it can be easily moved between room and can potentially be shared across facilities due to its compact size.
Financial Benefits for ASCs
Implementing the EVS can drive significant financial benefits for ASCs:
Expanded Procedure Offerings: ASCs can now offer EUS procedures, attracting new patients and retaining existing ones who would otherwise be referred to hospitals.
Increased Revenue: EUS procedures are reimbursed at the higher end of the EGD CPT code table, providing a new revenue stream for ASCs.
Improved Utilization: The addition of EUS can help optimize underutilized ASC capacity, increasing overall procedure volume and profitability. As the EVS works directly with your existing equipment, setup and room turnover is minimal, allowing EUS exams to be performed within the standard block schedule without delay.
Physician Satisfaction: By enabling gastroenterologists to perform advanced procedures in the ASC setting, the EVS can improve physician satisfaction and potentially attract new practitioners to the facility.
Case Study: Realizing the EVS Advantage
To illustrate the real-world impact of the EVS, consider the following case study from a current user:
An established gastroenterologist implemented the EVS in his ASC practice, with the following results:
Pre-Implementation (2023):
112 EUS cases performed over 8.5 months in a hospital endoscopy suite.
Post-Implementation (2024):
96 EUS procedures performed at the hospital endoscopy suite
88 EUS cases performed at the ASC using the EVS
Total EUS Volume:
With EUS now available at the ASC, more patients were scheduled for expanded indications including chronic abdominal pain and diarrhea, pancreatic cancer screenings, pancreatic cyst surveillance, dilated bile ducts, small gastric submucosal lesions, and others.
Case Study—Key Outcomes:
1. Practice Growth through Echo-Endoscopy:
The physician didn’t simply shift volume but significantly expanded his EUS practice.
This was accomplished by screening more patients with EUS, a term called Echo-Endoscopy meaning “Ultrasound-Enhanced Endoscopy”.
Using EUS in conjunction with regular EGD has the potential to enhance diagnostic yield and data from this case study confirms that result.
2. ASC Revenue Boost:
EUS procedures code with higher reimbursement
Increased volume of EGD and colonoscopy procedures on days allocated for EUS. When physicians schedule EUS exams, they will often perform additional EGD and colonoscopy cases to fill out their schedule.
3. Improved Efficiency:
The EVS allowed for efficient scheduling and performance of EUS procedures in the ASC setting.
4. Enhanced Patient Experience:
Patients benefited from the convenience and typically lower costs associated with ASC-based procedures.
This case study demonstrates that implementing EVS can be a win-win situation for gastroenterologists, ASCs, and patients alike.
A New Paradigm for EUS
The introduction of the EVS has the potential to create a new standard for EUS delivery, aligning it more closely with common procedures like EGD and colonoscopy. This shift promises several key benefits:
Conclusion
The EVS represents a significant advancement in making endoscopic ultrasound more accessible, efficient, and profitable in the ASC setting. By addressing the traditional barriers to EUS adoption, this innovative technology opens new possibilities for gastroenterologists, ASCs, and patients alike. As demonstrated in the case study, implementing EVS can lead to practice growth, increased ASC profitability, and improved patient care. Furthermore, with Echo-Endoscopy the practice used ultrasound with a standard EGD to drive more clinical results and increase volume.
The future of EUS lies in its broader adoption in outpatient settings, aligning with the ongoing shift towards value-based care. The EVS is at the forefront of this transformation, promising to revolutionize the delivery of advanced endoscopic services in gastroenterology.
Portland, OR, (June 18th, 2024) — EndoSound®, Inc., is thrilled to announce that the Centers for Medicare & Medicaid Services (CMS) has granted a Transitional Pass-Through (TPT) code, effective July 1, 2024, for the companies EndoSound Vision System™, or EVS™, a revolutionary advancement in endoscopic ultrasound (EUS) technology.
The CMS TPT status is monumental as it provides outpatient facilities with an incremental Medicare payment for procedures in which the EVS is utilized. This status is granted to new and innovative medical devices that meet eligibility criteria. Pass-through payments are intended to help facilitate patient access to new technologies. Details on the TPT code, C1606, can be found in the July 2024 update of the hospital outpatient prospective payment system, which is accessible on the CMS website.
“We are incredibly proud to receive the TPT status from CMS for the EVS,” said Scott Aldrich, CEO of EndoSound. “This approval underscores the clinical value and innovative nature of our technology. It enables broader access to the benefits of EUS, which is critical for early detection and treatment of gastrointestinal diseases. Our goal is to improve patient outcomes while reducing healthcare costs, and this milestone brings us a big step closer to achieving that.”
The EVS is an innovative, cost-effective solution designed to enhance the capabilities of existing endoscopic equipment, providing high-resolution ultrasound imaging without the need for expensive and complex new scopes. This breakthrough technology promises to improve the accessibility and quality of care for patients undergoing EUS procedures.
EndoSound remains committed to advancing medical technology and improving patient access to care.
About EndoSound
EndoSound, Inc., is a privately held company based in Portland, Oregon. EndoSound is dedicated to expanding access to endoscopic ultrasound technology around the world. With its patented design, EndoSound transforms any flexible upper endoscope into a fully functional EUS scope. EndoSound is comprised of an experienced team of scientists and engineers, clinicians, and seasoned business professionals with a track record of bringing new medical devices to market.
In partnership with Modo, Inc., we designed our EVSTM Cart to optimize convenience and stability. We are excited to share that this innovative design was recognized as a 2024 iF Design Award winner.
More than 10,000 entries were received from companies headquartered worldwide for the annual design competition. We hope this cart will play a valuable role in the endoscopy suite, saving time and maximizing workflow, and we are proud to be among this year’s selection of iF Design winners.
Past winners include Apple, Nikon, Siemens Healthineers, Philips, BMW Samsung, Google, and Canon Inc.
Revolutionizing Endoscopic Ultrasound in Ambulatory Surgical Centers: The EVS™ Advantage
Company NewsEndoscopic ultrasound (EUS) has long been a valuable diagnostic and therapeutic tool in gastroenterology, traditionally confined to hospital settings due to high costs and technical requirements. This white paper introduces the EndoSound Vision System™ (EVS™), a groundbreaking solution that makes EUS accessible and profitable for Ambulatory Surgical Centers (ASCs) and smaller hospitals. By addressing traditional barriers to EUS adoption in outpatient settings, EVS is poised to transform the landscape of advanced endoscopy, improving patient care, physician satisfaction, and ASC profitability.
Background: EUS in Gastroenterology
Endoscopic ultrasound (EUS) has been a cornerstone of advanced gastroenterology for over three decades. This hybrid technique combines endoscopy with high-frequency ultrasound, allowing for detailed imaging of the gastrointestinal tract and adjacent structures. EUS has proven invaluable for:
Despite its clinical utility, EUS has primarily been confined to hospital-based settings due to several limiting factors.
Traditional Barriers to EUS in ASCs
Historically, several factors have prevented the widespread adoption of EUS in the ASC:
These barriers have effectively relegated EUS to larger hospital settings, limiting access for patients and potentially increasing healthcare costs.
The EVS Solution
The EVS represents a paradigm shift in EUS technology, specifically designed to overcome the traditional barriers to ASC adoption. Key advantages include:
Financial Benefits for ASCs
Implementing the EVS can drive significant financial benefits for ASCs:
Case Study: Realizing the EVS Advantage
To illustrate the real-world impact of the EVS, consider the following case study from a current user:
An established gastroenterologist implemented the EVS in his ASC practice, with the following results:
With EUS now available at the ASC, more patients were scheduled for expanded indications including chronic abdominal pain and diarrhea, pancreatic cancer screenings, pancreatic cyst surveillance, dilated bile ducts, small gastric submucosal lesions, and others.
Case Study—Key Outcomes:
1. Practice Growth through Echo-Endoscopy:
2. ASC Revenue Boost:
3. Improved Efficiency:
4. Enhanced Patient Experience:
This case study demonstrates that implementing EVS can be a win-win situation for gastroenterologists, ASCs, and patients alike.
A New Paradigm for EUS
The introduction of the EVS has the potential to create a new standard for EUS delivery, aligning it more closely with common procedures like EGD and colonoscopy. This shift promises several key benefits:
Conclusion
The EVS represents a significant advancement in making endoscopic ultrasound more accessible, efficient, and profitable in the ASC setting. By addressing the traditional barriers to EUS adoption, this innovative technology opens new possibilities for gastroenterologists, ASCs, and patients alike. As demonstrated in the case study, implementing EVS can lead to practice growth, increased ASC profitability, and improved patient care. Furthermore, with Echo-Endoscopy the practice used ultrasound with a standard EGD to drive more clinical results and increase volume.
The future of EUS lies in its broader adoption in outpatient settings, aligning with the ongoing shift towards value-based care. The EVS is at the forefront of this transformation, promising to revolutionize the delivery of advanced endoscopic services in gastroenterology.
Further Information:
References:
1Procedure price lookup for outpatient services. Procedure Price Lookup for Outpatient Services. Accessed September 25, 2024. https://www.medicare.gov/procedure-price-lookup/cost/43259/.
EndoSound Vision System™ Granted Transitional CMS Pass-Through Code
Company NewsPortland, OR, (June 18th, 2024) — EndoSound®, Inc., is thrilled to announce that the Centers for Medicare & Medicaid Services (CMS) has granted a Transitional Pass-Through (TPT) code, effective July 1, 2024, for the companies EndoSound Vision System™, or EVS™, a revolutionary advancement in endoscopic ultrasound (EUS) technology.
The CMS TPT status is monumental as it provides outpatient facilities with an incremental Medicare payment for procedures in which the EVS is utilized. This status is granted to new and innovative medical devices that meet eligibility criteria. Pass-through payments are intended to help facilitate patient access to new technologies. Details on the TPT code, C1606, can be found in the July 2024 update of the hospital outpatient prospective payment system, which is accessible on the CMS website.
The EVS is an innovative, cost-effective solution designed to enhance the capabilities of existing endoscopic equipment, providing high-resolution ultrasound imaging without the need for expensive and complex new scopes. This breakthrough technology promises to improve the accessibility and quality of care for patients undergoing EUS procedures.
EndoSound remains committed to advancing medical technology and improving patient access to care.
About EndoSound
EndoSound, Inc., is a privately held company based in Portland, Oregon. EndoSound is dedicated to expanding access to endoscopic ultrasound technology around the world. With its patented design, EndoSound transforms any flexible upper endoscope into a fully functional EUS scope. EndoSound is comprised of an experienced team of scientists and engineers, clinicians, and seasoned business professionals with a track record of bringing new medical devices to market.
To learn more about the EVS, please visit endosound.com/endosound-vision-system
For media inquiries, please contact:
Patrick Hurley
VP of Marketing
pr@endosound.com
EVS™ Cart Receives 2024 iF Design Award
Company NewsIn partnership with Modo, Inc., we designed our EVSTM Cart to optimize convenience and stability. We are excited to share that this innovative design was recognized as a 2024 iF Design Award winner.
More than 10,000 entries were received from companies headquartered worldwide for the annual design competition. We hope this cart will play a valuable role in the endoscopy suite, saving time and maximizing workflow, and we are proud to be among this year’s selection of iF Design winners.
Past winners include Apple, Nikon, Siemens Healthineers, Philips, BMW Samsung, Google, and Canon Inc.
Learn more about the EVS cart and system.